Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells Better prediction of in vivo drug efficacy using in vitro models should greatly improve in vivo success. Here we utilize 3D highly porous chitosan-alginate complex scaffolds to probe how various components of the glioblastoma microenvironment including extracellular matrix and stromal cells affect tumor cell stem-like state.
The failure of new therapies in in vivo and clinical trials represents a costly bottleneck for new drug development. The vast majority of cancer drug development begins with in vitro testing using cell lines. However, many of these therapies that show promise in vitro fail during in vivo trials. Failure can be caused by various factors such as poor biodistribution, low serum stability, high off-target toxicity, and lower efficacy in cancer cells growing as part of the larger tumor microenvironment. The ability to better predict in vivo drug efficacy in vitro could rapidly accelerate novel drug development and reduce costs associated with these animal experiments. 1 We have developed 3D highly porous scaffolds of polyelectrolyte chitosan-alginate (CA) complexes for in vitro culture of cancer cells that better mimic the behavior of cells growing as part of a tumor than cells culture on 2D well plates. 2 We have shown that culturing cancer cells in these scaffolds drastically alters their growth, shape, and gene expression profile towards being more malignant. Indeed, we have shown enrichment of the cancer stem-like cell population indicating the more aggressive phenotype of cells cultured on these scaffolds, which was attributed to the 3D chemical extracellular matrix (ECM) environment afforded by the scaffolds. 3 However, the tumor microenvironment comprises not only ECM but contains a variety of stromal cells that can both affect tumor growth, progression, and stem-like state. 4 In fact, the tumor microenvironment has recently received significant attention in the development of new anti-cancer therapies. 4b, 5 Therefore, the ability to model, in vitro, how the various parts of the tumor microenvironment affect tumor behavior could greatly accelerate the development of these next-generation therapies. Our CA scaffolds are well suited to systematically test how each stromal compartment affects cancer cell behavior.
Here we aim to utilize our CA scaffolds to probe how the tumor microenvironment of glioblastoma (GBM), the most common and deadly brain cancer, affects their growth and malignancy. We test how differences in extracellular composition and stromal cell type affect the stem-like properties of GBM cells. CA scaffolds were coated with hyaluronic acid (HA), a major ECM protein in GBM, 6 or polycaprolactone (PCL) as a control to block the chemical structure of the CA scaffold so that only the 3D environment was present. GBM cells were also co-cultured in scaffolds with the primary stromal cells of GBM, astrocytes and endothelial cells.
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The effects of these changes in the tumor microenvironment on GBM cells were analyzed through protein and gene expression analyses.
CA scaffolds were coated with PCL as reported previously 3 to generate PCL-CA scaffolds, and coated with HA following a similar procedure to generate HA-CA scaffolds. HA was dissolved in acetic acid at 0.5% and then diluted in methanol to 0.05%. Scaffolds were added to the HA solution and allowed to coat for 4 hrs before quickly drying with an air gun, sterilized with 70% ethanol overnight, and then washed with PBS before use. HA coating was confirmed with FTIR ( Fig. 1b) . A unique characteristic peak at 1380 cm −1 from HA was observed in HA-CA scaffolds (Fig. S1 ) indicating HA present on the scaffolds. The presence of PCL was observed from the unique characteristic peak at 1750 cm -1 . To ensure pore structure was not altered, scaffolds were imaged using SEM (Fig. 1a) . Pore structure remained similar to uncoated CA scaffolds as determined from low magnification images. High magnification images show the uniform coating of PCL or HA on the surface of the scaffold walls. Cells (red fluorescent protein (RFP) expressing U-87 MG) were seeded (50,000 in 50 µL) on optimized coated scaffolds (uncoated, PCL, HA) and imaged over 8 days. Cells cultured in uncoated CA scaffolds showed similar growth as seen previously, 2b, 3 generating ~40 µm diameter tumor spheres within the scaffold in 8 days (Figure 2 ). Cells cultured in HA-CA scaffolds showed similar growth trend, but the number of tumor spheres within the scaffold was much more numerous (Fig. S2) . Cells cultured in PCL-CA scaffolds displayed a more elongated structure similar to that seen with 2D culture, and no tumor spheres were observed in the lower magnification images (Fig. S2) . On day 10, cells were imaged and collected for SEM, Western blot, and PCR analyses. SEM imaging confirmed that the cell structure observed with fluorescence imaging tumor spheroids in the CA and HA-CA scaffolds and elongated cells in the PCL-CA scaffolds (Fig. 3a-b) . Western blot was used to detect expression of CD44 and Id1 (Fig. S3) , whose increased expressions suggest an increase in the stem-like cell state of the cells.
8 Fig. 3c shows an increase in expression of both CD44
and Id1 protein in cells cultured in HA-CA scaffolds suggesting cells on these scaffolds were more stem-like. CD44 is the cell surface receptor for HA so is likely upregulated in response to Co-culture with either astrocytes or HUVECs resulted in smaller tumor spheres forming (Fig. S4) suggesting a slower growth rate of the tumor cells (Fig. 4) . Tumor spheres were observed to form around or on the stromal cells, which grew significantly slower, so final tumor sphere had only one to a few stromal cells associated with them. The lower ratio of stromal cell to tumor cell showed similar tumor sphere sizes to tumor cells grown without stromal cells likely because of the minimal number of tumor cells that had a stromal cell to incorporate with.
Western blot revealed an increased expression of CD44 and Id1 (Fig. S5 ) with increased ratios of astrocytes or HUVECs to U-87 MG cells (Fig. 5a-b) . Additionally, this increase was accompanied by increased CD133 mRNA abundance (Fig. 5c ) suggesting co-culture with stromal cells increased the stemlike properties of U-87 MG cells. This is in accordance with the smaller tumor spheres observed at higher stroma:tumor cell radios, since the slower growth of tumor cells may suggest reversion to a more stem-like state rather than simply uncontrolled cell proliferation, which we've observed previously. 3, 17 The slower growth of tumor spheres combined with the increased expression of stem-like cancer cell markers provides strong evidence that we can finely adjust the tumor microenvironment in vitro to better mimic in vivo conditions. In conclusion, we showed that altering the tumor microenvironment in vitro alters the expression of glioblastoma stem-like cell markers. This correlates well with the growing body of evidence that the stromal compartment plays a significant role in tumor aggressiveness and progression, and that this can be modeled in vitro. We found that both the chemical structure of the microenvironment and the presence of stromal cells impact glioblastoma stem-like cell state. We hope these modified scaffolds will be used to further probe how each stromal compartment affects tumor behavior in order to accelerate the development of more effective cancer therapies.
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